Drug Shortage Report for DIHYDROERGOTAMINE (DHE), 1MG/ML
Report ID | 115367 |
Drug Identification Number | 00027243 |
Brand name | DIHYDROERGOTAMINE (DHE), 1MG/ML |
Common or Proper name | DIHYDROERGOTAMINE MESYLATE INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | DIHYDROERGOTAMINE MESYLATE |
Strength(s) | 1MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 5 AMPOULES |
ATC code | N02CA |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-05-18 |
Estimated end date | |
Actual end date | 2020-07-08 |
Shortage status | Resolved |
Updated date | 2020-07-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-05-19 | English | Compare |
v2 | 2020-05-19 | French | Compare |
v3 | 2020-07-08 | English | Compare |
v4 | 2020-07-08 | French | Compare |
v5 | 2020-07-09 | English | Compare |
Showing 1 to 5 of 5